Skip to main content

Advertisement

Log in

Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Introduction

Ultrasound (US) preoperative examination of the axillary lymph nodes combined with the fine needle aspiration biopsy (FNAB) is often used in order to reduce the number of sentinel lymph node (SLN) biopsy procedures in clinically node negative breast cancer patients. The pathohistological characteristics of the ultrasonically negative axillary lymph nodes in clinically negative axillary lymph nodes are not known. The aim of our study was to compare the pathohistological characteristics of ultrasonically uninvolved axillary lymph nodes (US group) versus clinically uninvolved axillary lymph nodes (non-US group) in SLN biopsy candidates.

Methods

We included 658 patients after SLN biopsy; 286 patients in the US group and 372 in the non-US group. The pathohistological characteristics of axillary lymph nodes were evaluated by univariate analysis and logistic regression.

Results

In the univariate analysis, the proportion of macrometastastic SLN, total number of metastatic lymph nodes per patient, proportion of nonsentinel lymph node (NSLN) metastases and proportion of NSLN macrometastases were found to be lower in the US group compared to the non-US group. In the logistic regression model, only US of the axilla (p=0.010; OR: 0.57) and tumor size were significant predictors for the presence of SLN macrometastases or macrometastatic NSLN (p<0.001; OR: 0.23).

Conclusion

The patients with US negative axillary lymph nodes form a distinct subgroup of early breast cancer patients having a significantly lower tumor burden in the axillary lymph nodes compared to those with only clinically negative axillary lymph nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schwartz GF, Giuliano AE, Veronesi U,: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, PennsylvaniaCancer 94: 2542–2551, 2002

    Article  PubMed  Google Scholar 

  2. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R,: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancerN Engl J Med 349: 546–553, 2003

    Article  PubMed  Google Scholar 

  3. Torrenga H, Fabry H, van dS Jr., van Diest PJ, Pijpers R, Meijer S,: Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysisJ Surg Oncol 88: 4–7, 2004

    Article  PubMed  Google Scholar 

  4. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS, III,: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 proceduresAnn Surg 240: 462–468, 2004

    Article  PubMed  Google Scholar 

  5. Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, Lucas PC, Snyder ML, Chang AE, Newman LA,: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsCancer 98: 2307–2315, 2003

    Article  PubMed  Google Scholar 

  6. Sato K, Tamaki K, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H,: Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsyAm J Surg 187: 679–683, 2004

    Article  PubMed  Google Scholar 

  7. Greco M, Crippa F, Agresti R, Seregni E, Gerali A, Giovanazzi R, Micheli A, Asero S, Ferraris C, Gennaro M, Bombardieri E, Cascinelli N,: Axillary lymph node staging in breast cancer by 2–fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative managementJ Natl Cancer Inst 93: 630–635, 2001

    Article  PubMed  CAS  Google Scholar 

  8. Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR,: A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancerAnn Surg Oncol 11: 846–853, 2004

    Article  PubMed  Google Scholar 

  9. Bonnema J, van Geel AN, van Ooijen B, Mali SP, Tjiam SL, Henzen-Logmans SC, Schmitz PI, Wiggers T,: Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic methodWorld J Surg 21: 270–274, 1997

    Article  PubMed  CAS  Google Scholar 

  10. de Kanter AY, van Eijck CH, van Geel AN, Kruijt RH, Henzen SC, Paul MA, Eggermont AM, Wiggers T,: Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancerBr J Surg 86: 1459–1462, 1999

    Article  PubMed  Google Scholar 

  11. Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes OR, Schultze Kool LJ,: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerEur J Cancer 39: 1068–1073, 2003

    Article  PubMed  CAS  Google Scholar 

  12. Podkrajsek M, Music MM, Kadivec M, Zgajnar J, Besic N, Pogacnik A, Hocevar M,: Role of ultrasound in the preoperative staging of patients with breast cancerEur Radiol 15: 1044–1050, 2005

    Article  PubMed  Google Scholar 

  13. Zgajnar J, Frkovic-Grazio S, Besic N, Hocevar M, Vidergar-Kralj B, Gerljevic A, Pogacnik A,: Low sensitivity of the touch imprint cytology of the sentinel lymph node in breast cancer patients–results of a large seriesJ Surg Oncol 85: 82–86, 2004

    Article  PubMed  Google Scholar 

  14. Sobin LHWC. 2002. UICC TNM Classification of Malignant tumours, 6th edition. New York: John Wiley and Sons

    Google Scholar 

  15. Davies GC, Millis RR, Hayward JL,: Assessment of axillary lymph node status. Ann Surg 192: 148–151, 1980

    Article  PubMed  CAS  Google Scholar 

  16. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer 52: 1551–1557, 1983

    Article  PubMed  CAS  Google Scholar 

  17. Cutler SJ, Axtell LM, Schottenfeld D, Farrow JH,: Clinical assessment of lymph nodes in carcinoma of the breastSurg Gynecol Obstet 131: 41–52, 1970

    PubMed  CAS  Google Scholar 

  18. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M,: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breastSurg Gynecol Obstet 152: 765–772, 1981

    PubMed  CAS  Google Scholar 

  19. Specht MC, Fey JV, Borgen PI, Cody HS, III,: Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?J Am Coll Surg 200: 10–14, 2005

    Article  PubMed  Google Scholar 

  20. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS, III, Kattan MW,: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsyAnn Surg Oncol 10: 1140–1151, 2003

    Article  PubMed  Google Scholar 

  21. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE,: Predictors of non-sentinel lymph node metastasis in breast cancer patientsEur J Cancer 40: 1731–1737, 2004

    Article  PubMed  CAS  Google Scholar 

  22. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, Zurrida S, Maisonneuve P, Paganelli G, Mazzarol G,: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsyAnn Surg 241: 319–325, 2005

    Article  PubMed  Google Scholar 

  23. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, Giuliano AE,: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph nodeCancer 89: 574–581, 2000

    Article  PubMed  CAS  Google Scholar 

  24. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ, Carson WB, Burak WE, Jr: Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182: 316–320, 2001

    Article  PubMed  CAS  Google Scholar 

  25. Fisher ER, Anderson S, Redmond C, Fisher B,: Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminantsCancer 71: 2507–2514, 1993

    Article  PubMed  CAS  Google Scholar 

  26. Morrow M: A survival benefit from axillary dissection: was Halsted correct? Ann Surg Oncol 6: 17–18, 1999

    Article  PubMed  CAS  Google Scholar 

  27. den Bakker MA, van Weeszenberg A, de Kanter AY, Beverdam FH, Pritchard C, van der Kwast TH, Menke-Pluymers M,: Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearanceJ Clin Pathol 55: 932–935, 2002

    Article  PubMed  Google Scholar 

  28. Nos C, Harding-MacKean C, Freneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB,: Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastasesBr J Surg 90: 1354–1360, 2003

    Article  PubMed  CAS  Google Scholar 

  29. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Bussolati G, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Wells CA,: Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelinesEur J Cancer 39: 1654–1667, 2003

    Article  PubMed  CAS  Google Scholar 

  30. Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Harrison R,: Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical TrialAnn Surg Oncol 7: 87–97, 2000

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Janez Zgajnar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zgajnar, J., Hocevar, M., Podkrajsek, M. et al. Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients. Breast Cancer Res Treat 97, 293–299 (2006). https://doi.org/10.1007/s10549-005-9123-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9123-6

Keywords

Navigation